Obstetrics & Gynecology Doctors in Essex Junction, VT Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

George Till, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 55 Main St, Suite 3, Essex Junction, VT 05452 Phone: 802-879-1802    Fax: 802-878-6131

Kara Flaherty, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 55 Main St, Suite 3, Essex Junction, VT 05452 Phone: 802-879-1802    Fax: 802-878-6131

Dr. Maria G Carracino, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 55 Main St., Suite 3 Champlain Obstetrics & Gynecology, Essex Junction, VT 05452 Phone: 802-879-1802    Fax: 802-878-6131

Sally Stockwell, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 55 Main St, Suite 3, Essex Junction, VT 05452 Phone: 802-879-1802    Fax: 802-878-6131

John Gallagher, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 55 Main St, Suite 3, Essex Junction, VT 05452 Phone: 802-879-1802    Fax: 802-878-6131

Nathalie Feldman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 55 Main St, Suite 3, Essex Junction, VT 05452 Phone: 802-879-1802    Fax: 802-878-6131

News Archive

FDA dragging its heels yet again over 'morning after' pill Plan B

Women in the U.S., unlike their counterparts in the UK and other countries, will still be denied easy access to the 'morning after' contraceptive pill, Plan B, after a decision by the Food and Drug Administration to yet again delay ruling on over-the-counter sales.

SAFC Hitech plans new production facility in Taiwan for LED and silicon semiconductor precursors

Following the March 2010 production expansion of trimethylgallium (TMG) at its Bromborough, UK manufacturing site, SAFC Hitech®, a member of the Sigma-Aldrich® Group, reinforced its commitment to the Asia-Pacific electronics markets by announcing plans to build a new, dedicated facility in Kaohsiung, Taiwan for transfilling, technical service and production of LED and silicon semiconductor precursors.

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences, Inc. today announced Phase II clinical trial results showing that its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat and Truvada (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection maintained a high rate of virologic suppression through 48 weeks, exhibiting antiretroviral activity comparable to that of Atripla(efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

Eating potatoes provides as much fuel as carbohydrate gels for athletes

Eating a potato during exercise provides as much fuel and results in similar performance in trained athletes as carbohydrate gels.

Read more Medical News

› Verified 3 days ago